Hu Naonori, Nakamura Taiki, Kataura Ryusuke, Suga Keita, Mukawa Tetsuya, Akita Kazuhiko, Kakino Ryo, Sasaki Akinori, Nojiri Mai, Matsubayashi Nishiki, Takata Takushi, Tanaka Hiroki, Nihei Keiji, Ono Koji
Kansai BNCT Medical Center, Osaka Medical and Pharmaceutical University, Osaka, Japan.
Institute for Integrated Radiation and Nuclear Science, Kyoto University, Osaka, Japan.
J Appl Clin Med Phys. 2025 Aug;26(8):e70190. doi: 10.1002/acm2.70190.
Currently, the metal foil activation method is routinely used to measure the neutron output of an accelerator-based neutron source designed for clinical Boron neutron capture therapy (BNCT). Although this method is well established and has been primarily utilized since the nuclear reactor BNCT era, the process is labour-intensive and not well-suited for a busy hospital environment performing routine patient treatment. A replacement neutron detector system that is simple to use and can measure the neutron output in real-time is necessary.
Investigation and implementation of an Eu doped LiCaAlF scintillator detector for use in routine quality assurance tests of an accelerator-based neutron source designed for clinical BNCT.
The response of the scintillator detector was evaluated using the NeuCure BNCT system installed at the Kansai BNCT Medical Center. The measurement repeatability, neutron fluence linearity, and neutron flux dependency of the detector system were evaluated. The beam central axis and off-axis thermal neutron distribution inside a water phantom were measured and compared with the Monte Carlo treatment planning system (TPS).
The scintillator detector system showed high measurement repeatability with a coefficient of variation of less than 0.4%. The detector system showed linear response up to a proton charge of 3.6 C, and the response was stable between a proton current of 0.1 and 1 mA. Both the central axis and off-axis thermal neutron flux inside a water phantom matched closely with both the metal foil activation method and the Monte Carlo simulation results. The time it took to perform a routine quality assurance test was drastically reduced from 1.5 h down to a few minutes.
Implementation of this detector system in the clinic would significantly reduce the time required for routine QA, acceptance, and commissioning, and be a stepping stone to assist expansion of accelerator-based BNCT systems worldwide.
目前,金属箔活化法通常用于测量为临床硼中子俘获疗法(BNCT)设计的基于加速器的中子源的中子输出。尽管这种方法已经成熟,并且自核反应堆BNCT时代以来就一直被主要使用,但该过程劳动强度大,不太适合在繁忙的医院环境中进行常规患者治疗。因此,需要一种易于使用且能实时测量中子输出的替代中子探测器系统。
研究并应用掺铕的LiCaAlF闪烁体探测器,用于为临床BNCT设计的基于加速器的中子源的常规质量保证测试。
使用安装在关西BNCT医疗中心的NeuCure BNCT系统评估闪烁体探测器的响应。评估了探测器系统的测量重复性、中子注量线性和中子通量依赖性。测量了水模体内束流中心轴和离轴热中子分布,并与蒙特卡罗治疗计划系统(TPS)进行了比较。
闪烁体探测器系统显示出高测量重复性,变异系数小于0.4%。探测器系统在质子电荷量达到3.6 C时显示出线性响应,并且在质子电流为0.1至1 mA之间响应稳定。水模体内的中心轴和离轴热中子通量与金属箔活化法和蒙特卡罗模拟结果都紧密匹配。进行常规质量保证测试所需的时间从1.5小时大幅减少到几分钟。
在临床中应用该探测器系统将显著减少常规质量保证、验收和调试所需的时间,并成为协助全球基于加速器的BNCT系统扩展的一块垫脚石。